Clear Street raises BlackSky Technology stock price target on fundamentals

Clear Street raised its BlackSky price target to $42 from $41 and maintained a Buy rating, citing higher projected 2030 adjusted EBITDA of $158 million versus $156 million and a larger projected cash position; its 10x valuation multiple was unchanged. BlackSky reported third-quarter adjusted EPS of $0.10 versus analysts’ expected loss of $0.22, revenue of $43 million versus $39.56 million expected, and 118% year-over-year revenue growth, then raised full-year guidance. The positive outlook is tempered by a roughly 38% share-price decline since Clear Street’s August upgrade and continued cash burn.

Analysis

The valuation case is unusually long-dated: the cited low EBITDA multiples depend on 2029–30 estimates and an unchanged 10x terminal multiple, so they offer little protection if contract timing, conversion, or cash burn disappoints. A small upward estimate revision is not itself evidence that the valuation gap has closed. The key question is whether the higher-margin intelligence business can scale without satellite, data, and customer-acquisition costs consuming the incremental gross profit.

Potential upside is not limited to defense budgets: sovereign demand could diversify customers, while commercial use cases could create recurring demand. But Wall Street trading is an aspirational market, not yet proof of material revenue; commercial adoption may require different products, service levels, and sales cycles. Planet Labs is a relevant public-market comparison, but differences in product mix and economics make a simple multiple comparison unreliable.

Near term, post-earnings momentum may support the shares, but the large drawdown versus small-cap indices signals a high burden of proof. Over 1–3 months, watch guidance delivery, contract awards, backlog conversion, and cash use. Over 6–18 months, the thesis needs sustained commercial/sovereign wins and improving cash conversion—not just TAM expansion. The contrarian risk is that investors anchor on the 2029–30 multiple while discounting financing or dilution risk if cash burn persists. Verify cash runway, backlog quality, customer concentration, and the reconciliation of adjusted EBITDA to cash flow.

Key Decisions for Investors

• Avoid chasing the analyst target. For a high-risk growth sleeve, consider a staged, small long only after the next results confirm guidance and show that operating cash use is stabilizing; the article’s quoted $17.93 is a reference point, not a current entry signal.
• Set thesis checks around quarterly revenue and guidance delivery, backlog conversion, and cash burn. Reassess or exit if guidance is cut, contract conversion slips, or cash consumption worsens without a corresponding increase in funded awards.
• Treat sovereign and commercial opportunities as upside optionality until management discloses identifiable awards, repeat customers, or revenue contribution. Do not capitalize the broader TAM as though it were contracted demand.
• Before sizing a position, verify cash runway and financing needs, customer concentration, and the timing and funding status of large opportunities; these missing details determine whether reported growth can translate into per-share value.